Cargando…

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33

Nanobodies (Nbs) are the smallest antigen-binding, single domain fragments derived from heavy-chain-only antibodies from Camelidae. Among the several advantages over conventional monoclonal antibodies, their small size (12–15 kDa) allows them to extravasate rapidly, to show improved tissue penetrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romão, Ema, Krasniqi, Ahmet, Maes, Laila, Vandenbrande, Camille, Sterckx, Yann G.-J., Stijlemans, Benoit, Vincke, Cécile, Devoogdt, Nick, Muyldermans, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981622/ https://www.ncbi.nlm.nih.gov/pubmed/31906437 http://dx.doi.org/10.3390/ijms21010310

Ejemplares similares

Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021)

An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase
por: Odongo, Steven, et al.
Publicado: (2016)

Nanobodies for the Early Detection of Ovarian Cancer
por: Tran, Lan-Huong, et al.
Publicado: (2022)

Exploiting sequence and stability information for directing nanobody stability engineering
por: Kunz, Patrick, et al.
Publicado: (2017)

Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
por: De Vlaminck, Karen, et al.
Publicado: (2021)

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
por: Dekempeneer, Yana, et al.
Publicado: (2016)

Targeted Radionuclide Therapy with A (177)Lu-labeled Anti-HER2 Nanobody
por: D'Huyvetter, Matthias, et al.
Publicado: (2014)

Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
por: Sadeghnezhad, Golnaz, et al.
Publicado: (2019)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
por: Caljon, Guy, et al.
Publicado: (2012)

Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
por: Llauger, Gabriela, et al.
Publicado: (2021)

Correction: Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
por: Caljon, Guy, et al.
Publicado: (2012)

Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor
por: Van Campenhout, Raf, et al.
Publicado: (2021)

Development and Characterization of Nanobodies Targeting the Kupffer Cell
por: Zheng, Fang, et al.
Publicado: (2021)

The Therapeutic Potential of Nanobodies
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
por: Van Campenhout, Raf, et al.
Publicado: (2023)

Development of Nanobodies Targeting Peste des Petits Ruminants Virus: The Prospect in Disease Diagnosis and Therapy
por: Kinimi, Edson, et al.
Publicado: (2021)

Intrabody Targeting HIF-1α Mediates Transcriptional Downregulation of Target Genes Related to Solid Tumors
por: Hu, Yaozhong, et al.
Publicado: (2021)

Structural Basis for the Specific Neutralization of Stx2a with a Camelid Single Domain Antibody Fragment
por: Bernedo-Navarro, Robert Alvin, et al.
Publicado: (2018)

The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle
por: Gelkop, Sigal, et al.
Publicado: (2018)

A guide to: generation and design of nanobodies
por: Muyldermans, Serge
Publicado: (2020)

Sensitive Protein Detection Using Site-Specifically Oligonucleotide-Conjugated Nanobodies
por: Al-Amin, Rasel A., et al.
Publicado: (2022)

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
por: De Veirman, Kim, et al.
Publicado: (2021)

Specificity Evaluation and Disease Monitoring in Arthritis Imaging with Complement Receptor of the Ig superfamily targeting Nanobodies
por: Zheng, Fang, et al.
Publicado: (2016)

Development of a Nanobody-based lateral flow assay to detect active Trypanosoma congolense infections
por: Pinto Torres, Joar E., et al.
Publicado: (2018)

Development of Nanobodies Against Hemorrhagic and Myotoxic Components of Bothrops atrox Snake Venom
por: Bailon Calderon, Henri, et al.
Publicado: (2020)

Direct Immobilization of Engineered Nanobodies on Gold Sensors
por: Simões, Bárbara, et al.
Publicado: (2021)

Application of Single-Domain Antibodies (“Nanobodies”) to Laboratory Diagnosis
por: Pillay, Tahir S., et al.
Publicado: (2021)

Nanobodies and recombinant binders in cell biology
por: Helma, Jonas, et al.
Publicado: (2015)

Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes
por: Obishakin, Emmanuel, et al.
Publicado: (2014)

Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
por: Hu, Yaozhong, et al.
Publicado: (2017)

Agonistic nanobodies and antibodies to human VISTA
por: Ma, Yu-Heng Vivian, et al.
Publicado: (2021)

High Affinity Nanobodies against the Trypanosome brucei VSG Are Potent Trypanolytic Agents that Block Endocytosis
por: Stijlemans, Benoît, et al.
Publicado: (2011)

Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies
por: Chaikuad, Apirat, et al.
Publicado: (2014)

Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
por: Arezumand, Roghaye, et al.
Publicado: (2017)

Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015)

Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery
por: Debie, Pieterjan, et al.
Publicado: (2019)

The structural basis of nanobody unfolding reversibility and thermoresistance
por: Kunz, Patrick, et al.
Publicado: (2018)

Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis
por: Stijlemans, Benoit, et al.
Publicado: (2017)

Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region
por: Ben Abderrazek, Rahma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4d855s4loa52rl3u0gre048b7